These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 15708480)
1. Sleep and circadian abnormalities in a transgenic mouse model of Alzheimer's disease: a role for cholinergic transmission. Wisor JP; Edgar DM; Yesavage J; Ryan HS; McCormick CM; Lapustea N; Murphy GM Neuroscience; 2005; 131(2):375-85. PubMed ID: 15708480 [TBL] [Abstract][Full Text] [Related]
3. Characterization of the 3xTg-AD mouse model of Alzheimer's disease: part 1. Circadian changes. Sterniczuk R; Dyck RH; Laferla FM; Antle MC Brain Res; 2010 Aug; 1348():139-48. PubMed ID: 20471965 [TBL] [Abstract][Full Text] [Related]
4. EEG, activity, and sleep architecture in a transgenic AβPPswe/PSEN1A246E Alzheimer's disease mouse. Jyoti A; Plano A; Riedel G; Platt B J Alzheimers Dis; 2010; 22(3):873-87. PubMed ID: 20858963 [TBL] [Abstract][Full Text] [Related]
5. Age-dependent differential expression of BACE splice variants in brain regions of tg2576 mice. Zohar O; Pick CG; Cavallaro S; Chapman J; Katzav A; Milman A; Alkon DL Neurobiol Aging; 2005; 26(8):1167-75. PubMed ID: 15917100 [TBL] [Abstract][Full Text] [Related]
6. Asymmetric expression patterns of brain transthyretin in normal mice and a transgenic mouse model of Alzheimer's disease. Tsai KJ; Yang CH; Lee PC; Wang WT; Chiu MJ; Shen CK Neuroscience; 2009 Mar; 159(2):638-46. PubMed ID: 19167467 [TBL] [Abstract][Full Text] [Related]
7. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1. Ohno M; Chang L; Tseng W; Oakley H; Citron M; Klein WL; Vassar R; Disterhoft JF Eur J Neurosci; 2006 Jan; 23(1):251-60. PubMed ID: 16420434 [TBL] [Abstract][Full Text] [Related]
8. Severe motor neuron degeneration in the spinal cord of the Tg2576 mouse model of Alzheimer disease. Seo JS; Leem YH; Lee KW; Kim SW; Lee JK; Han PL J Alzheimers Dis; 2010; 21(1):263-76. PubMed ID: 20421695 [TBL] [Abstract][Full Text] [Related]
9. Reduced serum level of antibodies against amyloid beta peptide is associated with aging in Tg2576 mice. Sohn JH; So JO; Kim H; Nam EJ; Ha HJ; Kim YH; Mook-Jung I Biochem Biophys Res Commun; 2007 Sep; 361(3):800-4. PubMed ID: 17678618 [TBL] [Abstract][Full Text] [Related]
10. Progressive cognitive decline in a transgenic mouse model of Alzheimer's disease overexpressing mutant hAPPswe. Middei S; Daniele S; Caprioli A; Ghirardi O; Ammassari-Teule M Genes Brain Behav; 2006 Apr; 5(3):249-56. PubMed ID: 16594978 [TBL] [Abstract][Full Text] [Related]
11. Calpastatin levels affect calpain activation and calpain proteolytic activity in APP transgenic mouse model of Alzheimer's disease. Vaisid T; Kosower NS; Katzav A; Chapman J; Barnoy S Neurochem Int; 2007; 51(6-7):391-7. PubMed ID: 17513017 [TBL] [Abstract][Full Text] [Related]
13. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities. Savonenko A; Xu GM; Melnikova T; Morton JL; Gonzales V; Wong MP; Price DL; Tang F; Markowska AL; Borchelt DR Neurobiol Dis; 2005 Apr; 18(3):602-17. PubMed ID: 15755686 [TBL] [Abstract][Full Text] [Related]
14. Impaired muscarinic regulation of excitatory synaptic transmission in the APPswe/PS1dE9 mouse model of Alzheimer's disease. Goto Y; Niidome T; Hongo H; Akaike A; Kihara T; Sugimoto H Eur J Pharmacol; 2008 Mar; 583(1):84-91. PubMed ID: 18282567 [TBL] [Abstract][Full Text] [Related]
15. Longitudinal assessment of Alzheimer's beta-amyloid plaque development in transgenic mice monitored by in vivo magnetic resonance microimaging. Braakman N; Matysik J; van Duinen SG; Verbeek F; Schliebs R; de Groot HJ; Alia A J Magn Reson Imaging; 2006 Sep; 24(3):530-6. PubMed ID: 16892201 [TBL] [Abstract][Full Text] [Related]
17. Synaptic transmission is impaired prior to plaque formation in amyloid precursor protein-overexpressing mice without altering behaviorally-correlated sharp wave-ripple complexes. Hermann D; Both M; Ebert U; Gross G; Schoemaker H; Draguhn A; Wicke K; Nimmrich V Neuroscience; 2009 Sep; 162(4):1081-90. PubMed ID: 19477243 [TBL] [Abstract][Full Text] [Related]
18. Decreased phosphatidylethanolamine binding protein expression correlates with Abeta accumulation in the Tg2576 mouse model of Alzheimer's disease. George AJ; Holsinger RM; McLean CA; Tan SS; Scott HS; Cardamone T; Cappai R; Masters CL; Li QX Neurobiol Aging; 2006 Apr; 27(4):614-23. PubMed ID: 15941609 [TBL] [Abstract][Full Text] [Related]
19. Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease. Aucoin JS; Jiang P; Aznavour N; Tong XK; Buttini M; Descarries L; Hamel E Neuroscience; 2005; 132(1):73-86. PubMed ID: 15780468 [TBL] [Abstract][Full Text] [Related]
20. Lack of LDL receptor aggravates learning deficits and amyloid deposits in Alzheimer transgenic mice. Cao D; Fukuchi K; Wan H; Kim H; Li L Neurobiol Aging; 2006 Nov; 27(11):1632-43. PubMed ID: 16236385 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]